Skip to main content
. Author manuscript; available in PMC: 2017 Jun 16.
Published in final edited form as: Cell Rep. 2017 Apr 25;19(4):875–889. doi: 10.1016/j.celrep.2017.03.078

Figure 6. CBP loss in NTMH cells promotes tumorigenesis and mimics acetylation loss seen in TMH cells.

Figure 6

(A) Bar graph showing relative levels of 32 histone acetyltransferases and deacetylases between NTMH/TMH and NTMP/TMP cells. The Y–axis shows Log2 Fold Change values. The dotted line shows the cutoff of 2-fold change. (B-C) Graph showing relative levels of CBP histone acetyltransferase in (E) NTMH, TMH, NTMP and TMP cells and (F) NTMH cells harboring either control or CBP shRNAs. (D-G) Boxplots showing average normalized intensity for ChIP-string probes for (D, F) H2BK5Ac and (E, G) H4K5Ac in NTMH, TMH, NTMH cells harboring CBP shRNAs or NRASG12D expressing transformed melanocytes (M-NRAS). The plot is limited to those probes that were originally enriched in (D-E) NTMH cells or in (F-G) in TMH cells by ChIP-Seq experiments and validated by ChIP-String in Figure S2A-F. Asterisk (*) represents p<0.05 and double asterisk (**) represents p<0.001 (Wilcoxon Rank test) when comparisons are made to NTMH. (H) Kaplan-Meier curve showing tumor formation efficiency of NTMH cells harboring control or CBP shRNAs (shCBP-1 and shCBP-2).